Epigen Biosciences, Inc. Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Epigen Biosciences is a small biotechnology company based in San Diego, California, that acts as an incubator for life science projects with strong intellectual property. It collaborates with academic groups to advance early-stage ideas toward clinical development, providing strategic project management and medicinal chemistry support. The company emphasizes an efficient asset-development model that leverages a full team of experts while keeping overhead low, aiming for a 2- to 4-year timeline from IP to IND enablement and eventual partnering or sale.

Within the biotechnology research landscape, Epigen positions itself as a bridge between lead identification and clinical proof of concept, offering access to a full team of experts and resources to advance assets. Based in San Diego, the company seeks collaborations with larger pharmaceutical partners to bring assets through IND enablement and early clinical evaluation. In 2018, Epigen announced a collaboration with Novo Nordisk A/S, under which Novo Nordisk licensed its LPA1 receptor antagonist EPGN696 for development in diabetic and chronic kidney disease and other metabolic-syndrome–related conditions.

Sign up for free to view info

Company overview Employee directory